FDA issued a Warning Letter to Lonza Biologics, Inc. on 9/1/2011 for a later inspection.
483 Lonza Biologics Sep 2000

483 Lonza Biologics Sep 2000

Julie Bringger FDA, Stephen Brown FDA$595.00 - Available Now

FDA investigators audited the Lonza Biologics - Hopkinton, MA, United States facility and issued inspectional observations (via FDA 483) on 29 Sep 2000.

Product details

  • Category: Biologics
  • Inspection end: 29 Sep 2000
  • Location: Hopkinton, United States
  • FEI: 3001701602
Add To Cart